- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06614556
Quantifying the Trainability of Peripheral Nerve Function in Young and Older Adults.
September 23, 2024 updated by: Oklahoma State University
The purpose of this project is to identify the effects of hand grip resistance training on nerve speed of the hand muscles and to quantify whether age plays a role in those effects.
Two groups (young and older adults) underwent a 4-week resistance training intervention with nerve conduction velocity measured before and after.
There were also two control groups (young and older adults) who performed the testing 4 weeks apart, but did not engage in the intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Studies have shown that nerve speed slows with advancing age.
As a result, slower nerves may result in slower movement speed and can alter response time.
The investigators propose that a resistance training intervention may elicit positive adaptations to the nerves.
The purpose of this project is to identify the effects of hand grip resistance training on nerve speed of the hand muscles and to quantify whether age plays a role in those effects.
Two groups (young and older adults) underwent a 4-week, at-home, resistance training intervention with nerve conduction velocity (m/s) measured before and after.
There were also two control groups (young and older adults) who performed the testing 4 weeks apart, but did not engage in the intervention.
Other outcome measures included nerve size, via ultrasound, maximal handgrip strength, and hand dexterity.
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Stillwater, Oklahoma, United States, 74078
- Applied Neuromuscular Physiology Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Apparently healthy adults 18 - 100 years old.
Exclusion Criteria:
- If you have been notified by a physician to refrain from exercise due to cardiovascular issues.
- Known orthopedic or neuromuscular limitations or illness of the upper extremities.
- Known neuromuscular disorders.
- Individuals that are experiencing a fever (> 100.4° F) or have identified as symptomatic on the COVID-19 screening questionnaire may not participate at this time.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Young Training Group
Ages 18-35.
Performed 4 weeks of an at-home, hand grip resistance training intervention.
|
Participants in the training groups performed bilateral hand grip resistance training three times per week for four weeks using a specialized hand-grip kit provided to them.
Participants were provided with pictures and instructions for each exercise upon completion of the initial testing (PRE) session.
They were asked to perform 12 training sessions (approximately 30-45 mins) over the 4 weeks according to their schedule.
Each participant was asked to keep a training log to assist with accountability.
Those assigned to the control groups were asked to maintain their normal daily activities throughout the four weeks.
Other Names:
|
|
No Intervention: Young Control Group
Ages 18-35.
Did not perform the training intervention
|
|
|
Experimental: Older Training Group
Ages 60+.
Performed 4 weeks of an at-home, hand grip resistance training intervention.
|
Participants in the training groups performed bilateral hand grip resistance training three times per week for four weeks using a specialized hand-grip kit provided to them.
Participants were provided with pictures and instructions for each exercise upon completion of the initial testing (PRE) session.
They were asked to perform 12 training sessions (approximately 30-45 mins) over the 4 weeks according to their schedule.
Each participant was asked to keep a training log to assist with accountability.
Those assigned to the control groups were asked to maintain their normal daily activities throughout the four weeks.
Other Names:
|
|
No Intervention: Older Control Group
Ages 60+.
Did not perform the training intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor nerve conduction velocity (m/s)
Time Frame: Before and after 4 weeks of training (or just 4 weeks, for controls)
|
Conduction velocity of the median nerve, via nerve stimulation, as measured through EMG at the Flexor Digitorum Superficialis muscle
|
Before and after 4 weeks of training (or just 4 weeks, for controls)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nerve cross-sectional area (mm^2)
Time Frame: Before and after 4 weeks of training (or just 4 weeks, for controls)
|
The area within the visible borders of the nerve, as seen and measured via ultrasound
|
Before and after 4 weeks of training (or just 4 weeks, for controls)
|
|
Maximal strength (kg)
Time Frame: Before and after 4 weeks of training (or just 4 weeks, for controls)
|
Maximal handgrip strength using a handgrip dynamometer
|
Before and after 4 weeks of training (or just 4 weeks, for controls)
|
|
Hand motor dexterity (seconds)
Time Frame: Before and after 4 weeks of training (or just 4 weeks, for controls)
|
A timed Minnesota manual dexterity task
|
Before and after 4 weeks of training (or just 4 weeks, for controls)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jason M DeFreitas, PhD, Oklahoma State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2022
Primary Completion (Actual)
July 18, 2023
Study Completion (Actual)
July 18, 2023
Study Registration Dates
First Submitted
September 12, 2024
First Submitted That Met QC Criteria
September 23, 2024
First Posted (Actual)
September 26, 2024
Study Record Updates
Last Update Posted (Actual)
September 26, 2024
Last Update Submitted That Met QC Criteria
September 23, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-22-270
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.